The Institute of Physiology and Pathophysiology of Heidelberg University, Division of Cardiovascular Physiology offers a PhD position to work on the CD40 ligand-receptor dyad and its role in linking innate immunity to homeostasis in the early phase of atherosclerosis. The successful candidates will be enrolled in the Hartmut Hoffmann Berling International Graduate School of Molecular and Cellular Biology (HBIGS) of Heidelberg University, which provides an educational framework for young graduate students, both with a bioscience and with a medical background.
Study Subject(s): The PhD candidate will receive advanced training in vascular biology through lectures, courses and summer schools offered by the Integrated Research Training Group established within the CRC/TR23.
Course Level: Position is open for pursuing PhD research program at Heidelberg University.
Scholarship Provider: Heidelberg University, Germany
Scholarship can be taken at: Germany
Accreditation: Heidelberg University is accredited by the German Universities Excellence Initiative, LERU, Coimbra Group, U15 and EUA.
User Review
( votes)Eligibility: Personal qualifications:
-Master or diploma in biology, biochemistry or related fields;
-Knowledge of light microscopy, cell biology, and animal experimentation techniques or willingness to acquire the necessary skills
-Team-minded and flexible;
-Ability to rapidly familiarize him/herself with new research areas in theory and praxis.
Scholarship Open for International Students: Students of Germany can apply for this PhD position.
Scholarship Description: International group consists of 6 principal investigators, 5 postdocs and about 20 PhD and MD students. Heidelberg, home to Germany’s oldest university and one of the premier centres of biomedical research in Europe, provides ample opportunity for scientific exchange not only within the university, but with other renowned research institutions as well. The project is integrated in the Collaborative Research Centre/Transregio 23 funded by the German Research Foundation (DFG), which, in addition to researchers at Heidelberg University, includes groups at the German Cancer Research Centre, the University of Frankfurt and the Max Planck Institute in Bad Nauheim.
Number of award(s): Not Known
Duration of award(s): Not Known
What does it cover? The successful candidates will be enrolled in the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) of Heidelberg University, which provides an educational framework for young graduate students, both with a bioscience and with a medical background.
Selection Criteria: Not Known
Notification: Not Known
Online Application: The mode of applying is online.
Scholarship Application Deadline: Please submit your application via the HBIGS website by 31 August.
